Document is current
Any future updates will be listed below
-
Authors
Müller-Franzes, Gustav
Khader, Firas
Siepmann, Robert
Han, Tianyu
Kather, Jakob Nikolas
Nebelung, Sven
Truhn, Daniel
-
Funding
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 25 June 2025
First Online: 4 July 2025
Declarations
:
: DT received honoraria for lectures by Bayer, GE, and Philips and holds shares in StratifAI GmbH, Germany and in Synagen GmbH, Germany.FK holds shares in StratifAI GmbHJNK declares consulting services for Bioptimus, France; Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, Synagen GmbH, Germany, and has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Janssen, Merck, MSD, BMS, Roche, Pfizer and Fresenius.Other authors have no competing interest.
: This study was carried out in accordance with the Declaration of Helsinki.
